Innate Pharma Stock
Innate Pharma Stock
There is an upward development for Innate Pharma compared to yesterday, with an increase of €0.032 (1.970%).
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 1.970% | 4.141% | 9.354% | 5.196% | -12.632% | -17.166% | -53.527% |
| Valneva SE | -1.120% | -2.740% | -2.539% | 106.590% | 76.454% | -43.800% | -47.531% |
| Nanobiotix | 12.630% | 14.356% | 16.518% | 554.279% | 611.617% | 446.997% | 55.185% |
| Transgene S.A. | -1.070% | 13.827% | -26.534% | 28.771% | 34.599% | -47.011% | -43.574% |
